Sat, Sep 20, 2014, 11:32 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Opko Health, Inc. Message Board

biztechnologies 7 posts  |  Last Activity: Sep 17, 2014 5:10 PM Member since: Jan 2, 2003
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    bank of america

    by pokeysun Sep 17, 2014 5:04 PM
    biztechnologies biztechnologies Sep 17, 2014 5:10 PM Flag

    What are the chances Monitise is involved in some way?
    If yes, how do they earn any revenue?
    Does Apple Pay and BOA need Monitise to work?

  • biztechnologies by biztechnologies Sep 14, 2014 2:02 PM Flag

    I do not remember seeing a press release like this before.... Is IBM hiring 20% of Monitise workforce?

    What does it mean "move across to big blue"? Will they work for IBMor Monitise?

    This seems very good or quite concerning. Could be the prelude for a very close partnership...and more.

    Surprised there is not much talk of this???? Seems like a major fundamental change at teh company.

    Below is from the Financial Times (easy to search for)

    The tie-up will give lossmaking Monitise access to IBM’s client base of big corporate customers using cloud-based technologies, including global banks, said Monitise chief executive Alastair Lukies. A fifth of the company’s staff – about 200 workers in its professional services division – will move across to Big Blue.

  • Reply to

    The Money Event at CTIA Super Mobility Week

    by hawk4life1982 Sep 10, 2014 4:10 PM
    biztechnologies biztechnologies Sep 10, 2014 6:03 PM Flag

    Who from Monitise is speaking a this conference and when?

  • biztechnologies by biztechnologies Jul 15, 2014 10:38 AM Flag

    Google Chile and Sativex

    I found many Spanish stories and translated using Google translate, as follows:

    ISP allows import of drug derivative of marijuana for sick lupus

    EFE / The Clinic Online July 14, 2014 Tags: import marijuana, drug

    Share on Facebook Share on Twitter

    The Institute of Public Health announced today that allowed entry into the country of a drug derived from marijuana, which will be used by a patient suffering from lupus and breast cancer. This unprecedented event occurs in exceptional shape and includes a prescription supporting its use.


    The Public Health Institute (ISP) today announced that Chile allowed entry into the country of a drug derived from marijuana, which will be used by a patient suffering from lupus and breast cancer.

    The importation of the drug Sativex will be exceptionally from a medical indication supporting its use, but the cost will be funded by the patient Cecilia Hyder, local media reported.

    "For Cecilia Hyder ISP support is part of a process where we move from the point of view of public health, because we are giving the opportunity to provide a palliative solution to the various ailments of a patient who is only in this medicine a relief, "said the agency.

    The ISP has authorized at other times the specific import of this drug, but for various reasons has not materialized.

    In Chile marijuana is not sanctioned, but prohibited its cultivation and marketing, which in practice, becomes illegal.

    However, for some time the government has opened up the possibility of allowing medicinal use more widely and there have been street demonstrations to promote legalization.

    In several countries the "cannabis sativa" is used for the treatment of glaucoma, asthma, cancer, migraine, insomnia, and nausea associated with chemotherapy for cancer, multiple sclerosis, peripheral neuropathies nuisance and other neuromuscular disorders vomiting.

  • biztechnologies by biztechnologies Jul 2, 2014 12:00 PM Flag

    Primary Children’s Hospital In Utah Will Study Epidiolex
    July 2, 2014

    In an open-label observational trial at Primary Children’s hospital, 25 children and teens with treatment-resistant epilepsy who apply to be part of a new drug trial will, will receive Epidiolex, a liquid, purified form of cannabidiol (CBD), a nonpsychoactive chemical in marijuana.

    The primary goal will be to test the tolerability of Epidiolex and the optimal dose of CBD, a chemical shown to have powerful anti-seizure properties in children who have tried whole-plant marijuana extracts.

    Parent activists who pushed for Charlee’s Law — which frees Utahns with epilepsy to import whole-plant CBD extracts from states where #$%$ is legal — have long hoped Primary Children’s would study Epidiolex.

    But the timing of the study poses a challenge for families who are on a waiting list for a highly sought CBD oil made by Colorado Springs growers at the Realm of Caring Foundation.

    Those families will be eligible to apply for a Utah “hemp supplement” registration card starting July 8. But taking the oil could exclude them from participating in Primary Children’s study, which has an unknown start date.

    “It’s a decision point for families, to do this study or try a whole plant extract,” acknowledged Clark.

  • biztechnologies by biztechnologies Jul 2, 2014 11:56 AM Flag

    Study: Marijuana Slows Lou Gehrig's Disease

    New research suggests cannabis-based medicine may allow those afflicted with Lou Gehrig's disease to lead longer, more productive lives.

    Researchers from the Complutense University in Spain published their latest findings in the medical journal CNS Neuroscience & Therapeutics, which details an exploration into the effects of the cannabis-based pharmaceutical, Sativex on the debilitating and deadly wrath of ALS, or Lou Gehrig's disease. The consensus is that Sativex slows the progression of Lou Gehrig's disease in laboratory animals.

    The study, which was conducted by injecting mice in late stages of the disease with a combination of THC and CBD extracts, is consistent with previous studies that have found cannabinoids effective in hindering the evolution of Lou Gehrig's disease. Researchers conclude that while clinical trails are necessary to paint a more accurate portrait of the drug's effectiveness on the disease, they believe their findings "provide support that Sativex (or alternative Sativex-like combinations of phytocannabinoids) may serve as a novel disease-modifying therapy in ALS."

    This discovery could eventually change the fate of the nearly 30,000 Americans currently inflicted with the disease, which destroys the brain and spinal cord, and ultimately leads to paralysis and death.

    There are only six states in the US that allows the use of #$%$ for patients suffering from Lou Gehrig's disease: Arizona, Florida, Maine, Michigan, New Jersey and New Mexico. Because the federal government is working with Sativex manufacturer, GW Pharmaceuticals, there is a distinct possibility the drug will soon be FDA approved for clinical trials for ALS and many other serious conditions.

    After all, Sativex is currently being tested in America as a treatment for cancer and epilepsy patients, which is interesting considering marijuana continues to be unrecognized by t

  • biztechnologies biztechnologies Jun 30, 2014 9:21 AM Flag

    where is best place to see the most updated short interest?

8.42-0.06(-0.71%)Sep 19 4:06 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.